Skip to main content
. 2019 Feb 16;45(6):1257–1266. doi: 10.1093/schbul/sby191

Fig. 4.

Fig. 4.

Quantitative reverse transcription-polymerase chain reaction validation of differentially expressed miRNAs in the blood exosomes of SCZ patients. hsa-miR-206 (A), hsa-miR-144-3p (C), and hsa-miR-619-5p (E) expression in the blood exosomes of 100 cases and 100 controls. hsa-miR-206 (B), hsa-miR-144-3p (D), and hsa-miR-619-5p (F) in the blood exosomes of 57 FEDF SCZ patients, 43 CT SCZ patients, and 100 controls. FEDF, first-episode, drug-free; CT, chronically treated. **P < .01, ***P < .001.